Page 10 - Toby Maher News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate announcements from Redx Pharma plc, R&D Day and New Clinical Data for ROCK2 Inhibitor

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a rare disease pharmaceutical company developing innovative medicines for severe lung disorders...

Webinar On Thursday, September 30 @ 16:00 CET (10AM ET) With The Medical Doctors And IPF Experts Prof. Toby Maher and Prof. Joanna Porter. GOTHENBURG, Sweden, Sept. 22, 2021 /PRNewswire/

PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders Leading experts in the field will advise on clinical development of PureTech’s lead, wholly-owned product candidate, LYT-100, in idiopathic pulmonary fibrosis and other progressive fibrosing interstitial lu...

PureTech Health plc: PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders idiopathic pulmonary fibrosis and other progressive fibrosing interstitial lung diseases PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced the formation of its Clinical Advisory Board for idiopathic pulmonary fibrosis (IPF) and other progressive fibrosing interstitial lung d...